S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Avoro Capital Advisors/Q4 2023

Avoro Capital Advisors

Periodo: Q4 2023 · Depositato: 2024-02-14
Vedi su SEC EDGAR
AUM
$7.24B
Valore totale del portafoglio
Posizioni
42
Titoli dichiarati
Prima Posizione
APLS
9.2% $665.1M
Var. Trimestrali
+6 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2024-02-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
APLSAPELLIS PHARMACEUTICALS INC$665.1M9.19%$61.27
9.2%
UTHRUNITED THERAPEUTICS CORP$628.6M8.68%$227.35$555.91+144.5%
8.7%
ASNDASCENDIS PHARMA$473.0M6.53%$127.53$274.50+115.2%
6.5%
ARGXARGENX SE$469.7M6.49%$381.00$939.68+146.6%
6.5%
MDGLMADRIGAL PHARMACEUTICALS INC$437.1M6.04%$226.86$528.10+132.8%
6.0%
SRPTSAREPTA THERAPEUTICS INC$418.9M5.79%$96.21$19.28-80.0%
5.8%
BMRNBIOMARIN PHARMACEUTICAL INC$414.6M5.73%$98.05$58.99-39.8%
5.7%
XBISPDR SERIES TRUST - S&P BIOTECH$396.8M5.48%$89.68$160.46+78.9%
5.5%
FOLDAMICUS THERAPEUTICS INC$388.8M5.37%
5.4%
CERECEREVEL THERAPEUTICS HLDNG$320.4M4.42%
4.4%
KRYSKRYSTAL BIOTECH INC$318.3M4.40%$124.96$375.07+200.2%
4.4%
MRTXMIRATI THERAPEUTICS INC$287.1M3.97%
4.0%
CBAYCYMABAY THERAPEUTICS INC$262.4M3.63%
3.6%
XENEXENON PHARMACEUTICALS INC$261.0M3.61%$44.91$60.96+35.7%
3.6%
ALNYALNYLAM PHARMACEUTICALS INC$212.7M2.94%$194.93$312.78+60.5%
2.9%
ITCIINTRA-CELLULAR THERAPIES INC$161.5M2.23%
2.2%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$155.8M2.15%$59.55$18.95-68.2%
2.1%
KYMRKYMERA THERAPEUTICS INC$96.1M1.33%$25.35$113.51+347.8%
1.3%
GPCRSTRUCTURE THERAPEUTICS INC$95.1M1.31%$40.39$53.45+32.3%
1.3%
SNDXSYNDAX PHARMACEUTICALS INC$91.2M1.26%$21.86$21.82-0.2%
1.3%
BCRXBIOCRYST PHARMACEUTICALS INC$78.2M1.08%$6.07$9.84+62.1%
1.1%
IOVAIOVANCE BIOTHERAPEUTICS INC$54.5M0.75%$8.10$4.31-46.8%
0.8%
ROIVROIVANT SCIENCES LTD$52.2M0.72%$11.35$35.13+209.5%
0.7%
KURAKURA ONCOLOGY INC$42.9M0.59%$15.36$11.10-27.7%
0.6%
SYRESPYRE THERAPEUTICS INC$39.6M0.55%$21.40$86.63+304.8%
0.6%
KRTXKARUNA THERAPEUTICS INC$39.6M0.55%
0.6%
RCKTROCKET PHARMACEUTICALS INC$37.8M0.52%$29.50$3.84-87.0%
0.5%
ARWRARROWHEAD PHARMACEUTICALS INC$34.6M0.48%$31.01$83.99+170.8%
0.5%
MRNSMARINUS PHARMACEUTICALS INC$34.2M0.47%
0.5%
MNKDMANNKIND CORP$32.8M0.45%$3.92$4.52+15.3%
0.5%

Attività Trimestre su Trimestre

Q4 2023 vs. Q3 2023

Nuove Posizioni (6)

TickerEmittenteNozionaleDal Deposito
XBISPDR SERIES TRUST - S&P BIOTECH$396.8M+78.9%
ITCIINTRA-CELLULAR THERAPIES INC$161.5M
KRTXKARUNA THERAPEUTICS INC$39.6M
SLNOSOLENO THERAPEUTICS INC$31.6M
IMGNIMMUNOGEN INC$25.9M
TRMLTOURMALINE BIO INC$22.7M

Posizioni Chiuse (8)

TickerEmittenteNozionale
HZNPHORIZON THERAPEUTICS PLC$809.8M
SGENSEAGEN INC$373.3M
AKROAKERO THERAPEUTICS ORD$28.1M
TNGXTANGO THERAPEUTICS INC$25.0M
PMVPPMV PHARMACEUTICALS INC$18.4M
IKNAIKENA ONCOLOGY INC$7.1M
MCRBSERES THERAPEUTICS INC$6.0M
IOBTQIO BIOTECH INC$2.8M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SYRESPYRE THERAPEUTICS INC$39.4M+15951.1%+304.8%
CERECEREVEL THERAPEUTICS HLDNG$299.5M+690.7%
GPCRSTRUCTURE THERAPEUTICS INC$44.7M+133.3%+32.3%
MRUSMERUS N V$14.0M+100.0%
ARWRARROWHEAD PHARMACEUTICALS INC$19.4M+100.0%+170.8%
SNDXSYNDAX PHARMACEUTICALS INC$54.1M+65.2%-0.2%
VRCAVERRICA PHARMACEUTICALS INC$17.8M+35.4%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$41.8M+29.0%-68.2%

Ridotte (4)

TickerEmittenteNozionaleVar. AzioniDal Deposito
NUVLNUVALENT INC$-24.2M-78.0%
RAREULTRAGENYX PHARMACEUTICAL INC$-36.7M-76.7%
MRTXMIRATI THERAPEUTICS INC$-3.3M-26.7%
KYMRKYMERA THERAPEUTICS INC$42.5M-2.1%+347.8%
Torna agli Hedge Fund